振东制药：10月10日召开董事会会议

Group 1 - The core point of the article is that Zhendong Pharmaceutical announced a board meeting to discuss providing guarantees for its wholly-owned subsidiary [1] - For the first half of 2025, Zhendong Pharmaceutical's revenue composition includes: pharmaceutical production and sales accounting for 110.27%, medicinal herb planting at 31.67%, and technical services at 3.38%, with inter-segment eliminations at -45.32% [1] - As of the report, Zhendong Pharmaceutical has a market capitalization of 6.9 billion yuan [1]